LcrV mutants that abolish Yersinia type III injectisome function

Journal of Bacteriology

Volumn 195, Issue 4, 2013, Pages 777-787

  Ligtenberg, Katherine Given ^a,b   Miller, Nathan C ^a,b   Mitchell, Anthony ^a,b   Plano, Gregory V ^c   Schneewinda, Olaf ^a,b  

^a ARGONNE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Biclustering; Constant row; Differential co expression; Gene expression.

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; CALCIUM; LOW CALCIUM RESPONSE V TYPE III NEEDLE CAP PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; CALCIUM SIGNALING; CONTROLLED STUDY; DNA SEQUENCE; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STOP CODON; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; GENE EXPRESSION REGULATION, BACTERIAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MUTATION; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN CONFORMATION; TIME FACTORS; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS;

EID: 84873552875     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02021-12     Document Type: Article

References (50)

1. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP, Stainier I. 1998. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62:1315-1352.
2. Rosqvist R, Bolin I, Wolf-Watz H. 1988. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involved in the Yop2b protein. Infect. Immun. 56:2139-2143.
3. 2+ response operon encodes the V antigen of Yersinia pestis. Infect. Immun. 54:428-434.
4. Cornelis GR. 2002. Yersinia type III secretion: send in the effectors. J. Cell Biol. 158:401-408.
5. Rosqvist R, Magnusson KE, Wolf-Watz H. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13:964-972.
6. Cornelis GR. 2006. The type III injectisome. Nat. Rev. Microbiol. 4:811-825.
7. Sorg JA, Blaylock B, Schneewind O. 2006. Secretion signal recognition by YscN, the Yersinia type III secretion ATPase. Proc. Natl. Acad. Sci. U. S. A. 103:16490-16495.
8. Galan JE, Wolf-Watz H. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573.
9. Hoiczyk E, Blobel G. 2001. Polymerization of a single protein of the pathogen Yersinia enterocolitica into needles punctures eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 98:4669-4674.
10. Diepold A, Wiesand U, Amstutz M, Cornelis GR. 2012. Assembly of the Yersinia injectisome: the missing pieces. Mol. Microbiol. 85:878-892.
11. Mueller CA, Broz P, Muller SA, Ringler P, Erne-Brand F, Sorg I, Kuhn M, Engel A, Cornelis GR. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310:674-676.
12. Sorg JA, Miller NC, Schneewind O. 2005. Substrate recognition of type III secretion machines: testing the RNA signal hypothesis. Cell. Microbiol. 7:1217-1225.
13. Mueller CA, Broz P, Cornelis GR. 2008. The type III secretion system tip complex and translocon. Mol. Microbiol. 68:1085-1095.
14. 2+-responsive operon fusion in Yersinia pestis. Nature 322:834-836.
15. Lee VT, Mazmanian SK, Schneewind O. 2001. A program of Yersinia enterocolitica type III secretion reactions is triggered by specific host signals. J. Bacteriol. 183:4970-4978.
16. Nilles ML, Fields KA, Straley SC. 1998. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J. Bacteriol. 180:3410-3420.
17. Lee VT, Tam C, Schneewind O. 2000. LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells. J. Biol. Chem. 275:36869-36875.
18. Hakansson S, Schesser K, Persson C, Galyov EE, Rosqvist R, Homble F, Wolf-Watz H. 1996. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J. 15:5812-5823.
19. Hakansson S, Bergman T, Vanooteghem JC, Cornelis G, Wolf-Watz H. 1993. YopB and YopD constitute a novel class of Yersinia Yop proteins. Infect. Immun. 61:71-80.
20. Goguen JD, Yother J, Straley SC. 1984. Genetic analysis of the low calcium response in Yersinia pestis Mud1(Ap lac) insertion mutants. J. Bacteriol. 160:842-848.
21. Torruellas J, Jackson MW, Pennock JW, Plano GV. 2005. The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion. Mol. Microbiol. 57:1719-1733.
22. 2+-blind mutants of Yersinia pestis. J. Bacteriol. 164:704-711.
23. 2+ response, and virulence of Yersinia pestis. J. Bacteriol. 177:2530-2542.
24. Skrzypek E, Straley SC. 1993. LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis. J. Bacteriol. 175:3520-3528.
25. 2+ response. J. Bacteriol. 179:1307-1316.
26. Burrows TW. 1956. An antigen determining virulence in Pasteurella pestis. Nature 177:426-427.
27. DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O. 2006. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect. Immun. 74:4910-4914.
28. Derewenda U, Mateja A, Devedjiev Y, Routzahn KM, Evdokimov AG, Derewenda ZS, Waugh DS. 2004. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12:301-306.
29. Brubaker RR. 1969. Mutation rate to non-pigmentation in Pasteurella pestis. J. Bacteriol. 98:1404-1406.
30. Higuchi K. 1970. An improved chemically defined culture medium for strain L mouse cells based on growth responses to graded levels of nutrients including iron and zinc ions. J. Cell. Physiol. 75:65-72.
31. Cornelis GR, Colson C. 1975. Restriction of DNA in Yersinia enterocolitica detected by the recipient ability for a derepressed R factor from Escherichia coli. J. Gen. Microbiol. 87:285-291.
32. Cheng LW, Anderson DM, Schneewind O. 1997. Two independent type III secretion mechanisms for YopE in Yersinia enterocolitica. Mol. Microbiol. 24:757-765.
33. Miller NC, Quenee LE, Elli D, Ciletti N, Schneewind O. 2012. Polymor-phisms in the lcrV gene of Yersinia enterocolitica do not provide for escape from plague protective immunity. Infect. Immun. 80:1572-1582.
34. Ferracci F, Schubot FD, Waugh DS, Plano GV. 2005. Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion. Mol. Microbiol. 57:970-987.
35. Blaylock B, Berube BJ, Schneewind O. 2010. YopR impacts type III needle polymerization in Yersinia species. Mol. Microbiol. 75:221-229.
36. Olsson J, Edqvist PJ, Br10.1128/JB.02021-12öms JE, Forsberg A, Wolf-Watz H, Francis MS. 2004. The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains. J. Bacteriol. 186:4110-4123.
37. Ramamurthi KS, Schneewind O. 2002. Type III protein secretion in Yersinia species. Annu. Rev. Cell Dev. Biol. 18:107-133.
38. Cornelis G, Vanootegem JC, Sluiters C. 1987. Transcription of the yop regulon from Y. enterocolitica requires trans acting pYV and chromosomal genes. Microb. Pathog. 2:367-379.
39. Michiels T, Wattiau P, Brasseur R, Ruysschaert JM, Cornelis G. 1990. Secretion of Yop proteins by yersiniae. Infect. Immun. 58:2840-2849.
40. Anderson DM, Ramamurthi KS, Tam C, Schneewind O. 2002. YopD and LcrH regulate the expression of Yersinia enterocolitica YopQ at a posttranscriptional step and bind to yopQ mRNA. J. Bacteriol. 184:1287-1295.
41. DeBord K, Lee VT, Schneewind O. 2001. Roles of LcrG and LcrV during the type III targeting of effector Yops by Yersinia enterocolitica. J. Bacteriol. 183:4588-4598.
42. Quenee LE, Ciletti NA, Elli D, Hermanas T, Schneewind O. 2011. Prevention of pneumonic plague in mice, rats, guinea pigs and nonhuman primates with clinical grade rV10, rV10-2 or F1-V vaccines. Vaccine 29:6572-6583.
43. Broz P, Mueller CA, Muller SA, Phillipsen A, Sorg I, Engel A, Cornelis GR. 2007. Function and molecular architecture of the Yersinia injectisome tip complex. Mol. Microbiol. 65:1311-1320.
44. Quenee LE, Berube B, Segal J, Elli D, Ciletti NA, Anderson DM, Schneewind O. 2010. Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 28:1870-1876.
45. Benner GE, Andrews GP, Byrne WR, Strachan SD, Sample AK, Heath DG, Friedlander AM. 1999. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental infection in mice. Infect. Immun. 67:1922-1928.
46. - Yersinia pestis. Infect. Immun. 76:5181-5190.
47. Hamad MA, Nilles ML. 2007. Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis. J. Bacteriol. 189:6734-6739.
48. Sato H, Hunt ML, Weiner JJ, Hansen AT, Frank DW. 2011. Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa. PLoS One 6:e18356. doi:10.1371/journal.pone.0018356.
49. Sato H, Frank DW. 2011. Multi-functional characteristics of the Pseudomonas aeruginosa type III needle-tip protein, PcrV; comparison to orthologs in other Gram-negative bacteria. Front. Microbiol. 2:142. doi:10 .3389/fmicb.2011.00142.
50. Lee PC, Stopford CM, Svenson AG, Rietsch A. 2010. Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV. Mol. Microbiol. 75:924-941.